Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001536368-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 8, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,000
Total Value
$504,903.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 6, 2026 | Sale | 4,111 | $49.98 | $205,481.76 | 47,773 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 6, 2026 | Sale | 5,889 | $50.84 | $299,421.49 | 41,884 | Direct | โ | View Details |